Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Camrelizumab
Trade Name
Synonyms SHR-1210|INCSHR-1210
Drug Descriptions

Camrelizumab (SHR-1210) is an antibody that targets PD-1 (PDCD1) and inhibits binding of PD-L1 (CD274) and PD-L2 (PDCD1LG2), potentially resulting in activation of anti-tumor immune response and decreased tumor growth (PMID: 29358502, PMID: 32623573, PMID: 32581041).

DrugClasses Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 93
CAS Registry Number 1798286-48-2
NCIT ID C123816


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Camrelizumab Camrelizumab 0 0
Camrelizumab + Cisplatin + Gemcitabine Camrelizumab Cisplatin Gemcitabine 0 0
Camrelizumab + Famitinib + Nab-paclitaxel Camrelizumab Famitinib Nab-paclitaxel 0 0
Camrelizumab + Lenvatinib Camrelizumab Lenvatinib 0 0
Camrelizumab + Rivoceranib Camrelizumab Rivoceranib 0 0
Camrelizumab + Rivoceranib + SHR9146 Camrelizumab Rivoceranib SHR9146 0 0
Camrelizumab + SHR9146 Camrelizumab SHR9146 0 0
Camrelizumab + Tislelizumab + Trastuzumab Camrelizumab Tislelizumab Trastuzumab 0 0

Additional content available in CKB BOOST